TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22130826

Group type: EXPERIMENTAL
Intervention: Probiotic Escherichia coli Nissle 1917 (EcN), n=60, given for 12 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo, n=60, given for 12 weeks
Number of subjects: 120
Study: 20101174

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy (within 48 hours of admission)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control laparoscopic cholecystectomy (after resolution of abdominal pain and normalizing trend of laboratory enzymes)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control laparoscopic cholecystectomy
Number of subjects: 50
Study: 18052559

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine (100-200 mg/day)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study: 16086912

Group type: EXPERIMENTAL
Intervention: 20 Gy supplemental beam radiation
Number of subjects: 165

Group type: COMPARATOR
Intervention: 44 Gy supplemental beam radiation
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 20 Gy supplemental beam radiation (PSA <10 ng/ml)
Number of subjects: 165

Group type: COMPARATOR
Intervention: 44 Gy supplemental beam radiation (PSA <10 ng/ml)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 20 Gy supplemental beam radiation (PSA >10 ng/ml)
Number of subjects: 165

Group type: COMPARATOR
Intervention: 44 Gy supplemental beam radiation (PSA >10 ng/ml)
Number of subjects: 165
Study: 12150649

Group type: EXPERIMENTAL
Intervention: Adequate antidepressant treatment
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Less severe depression
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Being married
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: High personality dysfunction scores
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Adequate pharmacotherapy
Number of subjects: 165
Study: 9873968

Group type: EXPERIMENTAL
Intervention: Clonidine 75 micrograms
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Clonidine 150 micrograms
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 8552433

Group type: EXPERIMENTAL
Intervention: Prenatal dexamethasone (DEX)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 76
Study: 2371016

Group type: EXPERIMENTAL
Intervention: Solco‐trans device
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Haemonetics cell saver
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal volunteers
Number of subjects: 12
Study: 282073

Group type: EXPERIMENTAL
Intervention: Thiazide diuretics
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Therapy for hypertension
Number of subjects: 206
Study: 30857423

Group type: EXPERIMENTAL
Intervention: Ultrasound evaluation by a novice sonographer orthopedic surgeon
Number of subjects: 10

Group type: COMPARATOR
Intervention: Open exposure of the transverse carpal ligament (used as a reference standard)
Number of subjects: 10
Study: 30713100

Group type: EXPERIMENTAL
Intervention: Early removal of abdominal drainage (AD)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Standard removal of abdominal drainage (AD)
Number of subjects: 141
Study: 28212252

Group type: EXPERIMENTAL
Intervention: Structured predischarge discussion (DG)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 190
Study: 25569647

Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (Group F)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (Group S)
Number of subjects: 80
Study: 23052625

Group type: EXPERIMENTAL
Intervention: Diet only (DI)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Diet and exercise (DI + EXE)
Number of subjects: 48
Study: 20816033

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 0
Study: 18282726

Group type: EXPERIMENTAL
Intervention: Neurology consultation
Number of subjects: 158

Group type: COMPARATOR
Intervention: Referral letter
Number of subjects: 158

Group type: COMPARATOR
Intervention: History taking in clinic
Number of subjects: 158

Group type: COMPARATOR
Intervention: Physical examination
Number of subjects: 158

Group type: COMPARATOR
Intervention: Investigations
Number of subjects: 158

Group type: COMPARATOR
Intervention: Neuro-imaging
Number of subjects: 158

Group type: COMPARATOR
Intervention: EEG
Number of subjects: 158

Group type: COMPARATOR
Intervention: Cardiac testing
Number of subjects: 158

Group type: COMPARATOR
Intervention: Blood tests
Number of subjects: 158
Study: 17239279

Group type: EXPERIMENTAL
Intervention: Neoadjuvant hormonal therapy with bicalutamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Escalated-dose external-beam radiation therapy
Number of subjects: 0
Study: 12481147

Group type: EXPERIMENTAL
Intervention: L-arginine (300 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11217015

Group type: EXPERIMENTAL
Intervention: 0 kg external load
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 5 kg external load
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 10 kg external load
Number of subjects: 42
Study: 9140680

Group type: EXPERIMENTAL
Intervention: Lisinopril 5 mg orally once per day (max 20 mg once per day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Captopril 12.5 mg orally once per day (max 25 mg twice per day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lisinopril 5-20 mg once daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Captopril 12.5-50 mg daily
Number of subjects: 100
Study: 8197755

Group type: EXPERIMENTAL
Intervention: 600 mg S(+) ibuprofen daily (3 x 200mg) for 14 days
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 900 mg S(+) ibuprofen daily (3 x 300mg) for 14 days
Number of subjects: 41
Study: 3585223

Group type: EXPERIMENTAL
Intervention: Dopamine (1.0 microgram/kg per min) with angiotensin II infusion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dopamine infusion (graded doses: 0.5, 1 and 5 micrograms/kg per min) with angiotensin II (6 ng/kg per min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo with angiotensin II infusion
Number of subjects: 6
Study: 1646068

Group type: EXPERIMENTAL
Intervention: Single-dose dactinomycin (60 micrograms/kg x 1 day)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Fractionated-dose dactinomycin (15 micrograms/kg/d x 5 days)
Number of subjects: 176
Study: 1274885

Group type: EXPERIMENTAL
Intervention: Daily protein intake of 29 g
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Daily protein intake of 54 g
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Daily protein intake of 84 g
Number of subjects: 12
Study: 31558274

Group type: EXPERIMENTAL
Intervention: 2-implant group (n=22)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Single-implant group (n=11)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Single-implant participants
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2-implant participants
Number of subjects: 24
Study: 30858346

Group type: EXPERIMENTAL
Intervention: Dual users of cigarettes and e-cigarettes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cigarette users
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dual users
Number of subjects: 0
Study: 28912947

Group type: EXPERIMENTAL
Intervention: Friction massage
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Number of subjects: 58
Study: 25888114

Group type: EXPERIMENTAL
Intervention: Tai Chi Yunshou exercise
Number of subjects: 250

Group type: COMPARATOR
Intervention: Balance rehabilitation training
Number of subjects: 250
Study: 23808108

Group type: EXPERIMENTAL
Intervention: Lifestyle counseling (modified Mediterranean diet and moderate physical exercise for 30 min/day)
Number of subjects: 53
Study: 21130598

Group type: EXPERIMENTAL
Intervention: Short, metaphyseal‐fitting femoral component
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional metaphyseal‐ and diaphyseal‐filling femoral component
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 19643002

Group type: EXPERIMENTAL
Intervention: Yoga intervention group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study: 17197963

Group type: EXPERIMENTAL
Intervention: Narrow resection margin (1 cm)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Wide resection margin (2 cm)
Number of subjects: 169
Study: 12835983

Group type: COMPARATOR
Intervention: CO(2) with placebo
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Mebeverine
Number of subjects: 181
Study: 10783998

Group type: EXPERIMENTAL
Intervention: Sulphasalazine
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Non-sulphasalazine 5-ASA drug
Number of subjects: 133

Group type: COMPARATOR
Intervention: Irritable bowel syndrome (control)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Ulcerative colitis
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Crohn's disease
Number of subjects: 133
Study: 8875814

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 5‐mg, 10‐mg, 15‐mg, 20‐mg
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Attentional Training (AT)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 2
Study: 1425620

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 0
Study: 6337306

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg daily postoperatively
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 31045768

Group type: EXPERIMENTAL
Intervention: Sanao decoction (SAD)
Number of subjects: 0
Study: 27649641

Group type: EXPERIMENTAL
Intervention: Gonadotropin‐releasing hormone agonist (GnRHa) goserelin
Number of subjects: 58
Study: 25960403

Group type: EXPERIMENTAL
Intervention: Hybrid cycle
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Handcycle
Number of subjects: 19

Group type: COMPARATOR
Intervention: Hybrid cycle and Handcycle
Number of subjects: 19
Study: 24091175

Group type: EXPERIMENTAL
Intervention: Prophylactic doses of low molecular weight heparin
Number of subjects: 50
Study: 21779829

Group type: EXPERIMENTAL
Intervention: Laparoscopic sigmoid resection (LSR)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Open sigmoid resection (OSR)
Number of subjects: 143
Study: 19786444

Group type: EXPERIMENTAL
Intervention: Family-based behavioral weight control intervention
Number of subjects: 192

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Family-based behavioral weight control intervention (for children attending > or =75% of sessions)
Number of subjects: 192
Study: 16394886

Group type: EXPERIMENTAL
Intervention: Subcutaneous bolus injection of deferoxamine (DFO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Subcutaneous continuous infusion of deferoxamine (DFO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Subcutaneous bolus injection and Subcutaneous continuous infusion)
Number of subjects: 20
Study: 15349783

Group type: EXPERIMENTAL
Intervention: SCI
Number of subjects: 12

Group type: COMPARATOR
Intervention: AB
Number of subjects: 12
Study: 11117271

Group type: EXPERIMENTAL
Intervention: Local allergoid immunotherapy for 3 months before the pollen season
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9338948

Group type: EXPERIMENTAL
Intervention: Extra self‐administered fitness training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 7505143

Group type: EXPERIMENTAL
Intervention: Vaccinated group
Number of subjects: 153

Group type: COMPARATOR
Intervention: Non-vaccinated group
Number of subjects: 153

Group type: COMPARATOR
Intervention: AntiHBs and antiHBc positive infants
Number of subjects: 153
Study: 3887393

Group type: EXPERIMENTAL
Intervention: Conventional treatment with anti-thymocyte globulin (ATG)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Cyclosporine (Cys) alone
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Sequential combination of ATG with Cys
Number of subjects: 88
Study: 31491931

Group type: EXPERIMENTAL
Intervention: Forest resting environments (7 types)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Water landscape environment
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Most natural environment
Number of subjects: 96
Study: 30821824

Group type: EXPERIMENTAL
Intervention: Gabapentin (1200 mg preoperatively, 600 mg 3 times a day postoperatively for 72 hours)
Number of subjects: 422

Group type: COMPARATOR
Intervention: Active placebo (lorazepam 0.5 mg preoperatively, inactive placebo postoperatively for 72 hours)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Worst pain reported on postoperative day 10
Number of subjects: 422
Study: 28159043

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (Group 1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No prophylactic antibiotics (Group 2)
Number of subjects: 100
Study: 26643736

Group type: EXPERIMENTAL
Intervention: FFR-guided group (n=114)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Routine-DES group (n=115)
Number of subjects: 229
Study: 21864917

Group type: EXPERIMENTAL
Intervention: High-dose bolus tirofiban
Number of subjects: 745

Group type: COMPARATOR
Intervention: Abciximab
Number of subjects: 745

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 745

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 745
Study: 21975093

Group type: EXPERIMENTAL
Intervention: Anesthetic block of the anterior and posterior interosseous nerves
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline injection (control)
Number of subjects: 80
Study: 18315419

Group type: EXPERIMENTAL
Intervention: DBM
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: GTR
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Other BRGs
Number of subjects: 55

Group type: COMPARATOR
Intervention: OFD
Number of subjects: 55
Study: 17059294

Group type: EXPERIMENTAL
Intervention: 24-week worksite exercise/behavioral intervention
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study: 12635534

Group type: EXPERIMENTAL
Intervention: Azithromycin alone (500 mg i.v. for 1-2 days, then 250 mg orally for 7 days)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Azithromycin with metronidazole (500 mg i.v. for 1-2 days, then 250 mg orally for 7 days + 400 mg or 500 mg metronidazole i.v. then orally for 12-14 days)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Comparator regimens (metronidazole + doxycycline + cefoxitin + probenecid or doxycycline + amoxycillin/clavulanate for up to 21 days)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: All treatment groups (including azithromycin alone, azithromycin with metronidazole, and comparator regimens)
Number of subjects: 309
Study: 10874261

Group type: EXPERIMENTAL
Intervention: Enalaprilat infusion (3-hour duration)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (historic)
Number of subjects: 7
Study: 9412796

Group type: EXPERIMENTAL
Intervention: Transurethral resection (TUR)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Age-matched control group
Number of subjects: 186
Study: 8517425

Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg) administered once daily at bedtime
Number of subjects: 408

Group type: COMPARATOR
Intervention: Placebo administered once daily at bedtime
Number of subjects: 408
Study: 2896557

Group type: EXPERIMENTAL
Intervention: High bio-availability glaphenine
Number of subjects: 78

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 78
Study: 30405295

Group type: EXPERIMENTAL
Intervention: CCTA
Number of subjects: 940

Group type: COMPARATOR
Intervention: Standard ED evaluation
Number of subjects: 940
Study: 28458078

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing designed to elicit change talk
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo counseling designed not to elicit change talk
Number of subjects: 100

Group type: COMPARATOR
Intervention: No additional treatment
Number of subjects: 100
Study: 24975233

Group type: EXPERIMENTAL
Intervention: Sentence training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Passive exposure
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Consonant training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Test-only
Number of subjects: 40
Study: 23653431

Group type: EXPERIMENTAL
Intervention: Vitamin D- and calcium-fortified yogurt (FY) providing 10 μg/d vitamin D₃ and 800 mg/d calcium
Number of subjects: 56

Group type: COMPARATOR
Intervention: Nonfortified control yogurt (CY) providing 280 mg/d calcium
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Vitamin D- and calcium-fortified yogurt (FY)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Nonfortified control yogurt (CY)
Number of subjects: 56
Study: 20559103

Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine combined with SCS
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intrathecal baclofen combined with SCS
Number of subjects: 10

Group type: COMPARATOR
Intervention: SCS alone
Number of subjects: 10
Study: 19098696

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 0
Study: 16311044

Group type: EXPERIMENTAL
Intervention: Oscillating floor at frequencies of 0.1, 0.5, 1.0, and 1.5 Hz
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Posterior-dominant muscles in the trunk and thigh
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Trunk muscles
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Thigh muscles
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Soleus and gastrocnemius muscles
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Comparison of periodicity between soleus and gastrocnemius
Number of subjects: 23
Study: 12727703

Group type: EXPERIMENTAL
Intervention: Cognitive behavior self-help
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Nonspecific self-help
Number of subjects: 85

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 85
Study: 10799795

Group type: EXPERIMENTAL
Intervention: Diclofenac epolamine patch applied twice daily for 2 weeks
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo patch applied twice daily for 2 weeks
Number of subjects: 222
Study: 8582495

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pindolol
Number of subjects: 24
Study: 2212207

Group type: EXPERIMENTAL
Intervention: Experimental teeth with orthodontic band allowing plaque accumulation for 1 day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Experimental teeth with orthodontic band allowing plaque accumulation for 2 days
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Experimental teeth with orthodontic band allowing plaque accumulation for 4 days
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Experimental teeth with orthodontic band allowing plaque accumulation for 8 days
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Experimental teeth with orthodontic band allowing plaque accumulation for 14 days
Number of subjects: 11
Study: 352183

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methohexitone
Number of subjects: 0
Study: 31172116

Group type: EXPERIMENTAL
Intervention: Nebulized budesonide
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 41
Study: 27671372

Group type: EXPERIMENTAL
Intervention: The Canary System
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: DIAGNOdent
Number of subjects: 105
Study: 26394017

Group type: EXPERIMENTAL
Intervention: Usual care plus telemedicine (n=24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care (n=26)
Number of subjects: 50
Study: 23224717

Group type: EXPERIMENTAL
Intervention: Selective reporting of antibiotic susceptibility data (2 to 4 antibiotics only)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Usual full-length reporting of antibiotic susceptibility data (25 antibiotics)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Selective reporting of antibiotic susceptibility data
Number of subjects: 326

Group type: COMPARATOR
Intervention: Usual full-length reporting of antibiotic susceptibility data
Number of subjects: 326
Study: 22010525

Group type: EXPERIMENTAL
Intervention: Earlier rescue group (rescue ICSI performed between 4 and 6 hours after insemination)
Number of subjects: 112
Study: 18280940

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid sutures
Number of subjects: 55

Group type: COMPARATOR
Intervention: Silk sutures
Number of subjects: 55

Group type: COMPARATOR
Intervention: Chlorhexidine solution
Number of subjects: 55
Study: 17268121

Group type: EXPERIMENTAL
Intervention: Elevated hsCRP level
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Low CVrr (below the 5 percentile)
Number of subjects: 823
Study: 12673748

Group type: EXPERIMENTAL
Intervention: Local quality assurance system at Uppsala University Hospital (UUH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: National Board of Health and Welfare (NBH) register
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regional Oncological Centres (ROC) register
Number of subjects: 0
Study: 11118018

Group type: EXPERIMENTAL
Intervention: NPH insulin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of insulin lispro (CSII)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ultralente human insulin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Long-acting insulin analog glargine
Number of subjects: 20
Study: 9007918

Group type: EXPERIMENTAL
Intervention: Topical fluocinolone acetonide 0.1%
Number of subjects: 33

Group type: COMPARATOR
Intervention: Topical retinoic acid 0.05%
Number of subjects: 33
Study: 8117604

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (cisplatin 100 mg/m2 on day 1 and etoposide 120 mg/m2 on days 1, 2, 3 every 3 weeks for 3 courses followed by radiotherapy 56 Gy on pre-treatment tumor volume and 40 Gy on mediastinum and bilateral supraclavicular nodes)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Radiotherapy alone (40 Gy on mediastinum and bilateral supraclavicular nodes)
Number of subjects: 66